Medicinal product name Ratiograstim
Biosimilar medicine
Pharmaceutical form Solution for injection/infusion
Strength 30 MIU (300 µg/0.5 ml) 
Information from the MAH on shortages Not available
predicted availability date: not notified
Legal status Rx Prescription (Pr.)
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code L03AA02 Immunostimulants

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers)
predicted availability date: not notified
currently no information on availability from any wholesaler N5
(300 µg/0,5 ml)
Glass pre-filled syringe without safety device    EU/1/08/444/002  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/08/444/002
Date of authorisation Sep 15, 2008
Marketing authorisation holder, country Ratiopharm GmbH, Germany